Cargando…

New Anti-CGRP Medications in the Treatment of Vestibular Migraine

BACKGROUND: Vestibular migraine (VM) is a condition associated with migraine headache, vertigo, dizziness, and balance disturbances. Treatment options are limited. It is unknown if new calcitonin gene-related peptide (CGRP) migraine medications have efficacy in treating VM. METHODS: We retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoskin, Justin L., Fife, Terry D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828914/ https://www.ncbi.nlm.nih.gov/pubmed/35153979 http://dx.doi.org/10.3389/fneur.2021.799002

Ejemplares similares

Rodent behavior following a dural inflammation model with anti-CGRP migraine medication treatment
por: Reducha, Philip V., et al.
Publicado: (2023)

CGRP and Migraine: What Have We Learned From Measuring CGRP in Migraine Patients So Far?
por: Kamm, Katharina
Publicado: (2022)

Dural Immune Cells, CGRP, and Migraine
por: Balcziak, Louis K., et al.
Publicado: (2022)

The Vasodilatory Response to CGRP of the Anterior and Posterior Cerebral Circulation in Migraine
por: Visočnik, Darja, et al.
Publicado: (2022)

Monoclonal Antibodies Targeting CGRP: A Novel Treatment in Vestibular Migraine
por: Lovato, Andrea, et al.
Publicado: (2023)

Auditory Manifestations of Vestibular Migraine
por: Shi, Suming, et al.
Publicado: (2022)

Efficacy and Safety of Anti-calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibodies in Preventing Migraines: A Systematic Review
por: Muddam, Meghana Reddy, et al.
Publicado: (2023)

Effects of Vestibular Rehabilitation in the Management of a Vestibular Migraine: A Review
por: Alghadir, Ahmad H., et al.
Publicado: (2018)

Characteristics of vestibular migraine, probable vestibular migraine, and recurrent vertigo of childhood in caloric and video head impulse tests
por: Zhang, Qin, et al.
Publicado: (2022)

Enhanced Hemodynamic and Clinical Response to αCGRP in Migraine Patients—A TCD Study
por: Visočnik, Darja, et al.
Publicado: (2021)

Real-World Evidence for the Safety and Efficacy of CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatment for Migraine Prevention in Adult Patients With Chronic Migraine
por: Mechtler, Laszlo, et al.
Publicado: (2022)

Commentary: Enhanced Hemodynamic and Clinical Response to αCGRP in Migraine Patients—A TCD Study
por: Altamura, Claudia, et al.
Publicado: (2021)

CGRP in migraine
por: Tfelt-Hansen, Peer, et al.
Publicado: (2009)

CGRP and migraine
por: Cauchi, M., et al.
Publicado: (2016)

Errors of Upright Perception in Patients With Vestibular Migraine
por: Winnick, Ariel, et al.
Publicado: (2018)

Vestibular Migraine and Tinnitus: A Challenging Narrative
por: García, Alejandro, et al.
Publicado: (2021)

Acute Medication Use in Patients With Migraine Treated With Monoclonal Antibodies Acting on the CGRP Pathway: Results From a Multicenter Study and Proposal of a New Index
por: Sette, Lucia, et al.
Publicado: (2022)

Effect of switching to erenumab in non-responders to a CGRP ligand antibody treatment in migraine: A real-world cohort study
por: Overeem, Lucas Hendrik, et al.
Publicado: (2023)

TRPM7 as a Candidate Gene for Vestibular Migraine
por: Oh, Eun Hye, et al.
Publicado: (2020)

Evaluating children with vestibular migraine through vestibular test battery: A cross-sectional investigation
por: Zhang, Fan, et al.
Publicado: (2022)

Recurrent Vestibular Symptoms Not Otherwise Specified: Clinical Characteristics Compared With Vestibular Migraine and Menière's Disease
por: Dlugaiczyk, Julia, et al.
Publicado: (2021)

A case report of a chronic migraine patient treated with three different anti-CGRP monoclonal antibodies: which parameters better represent the efficacy?
por: Uzun, Sena, et al.
Publicado: (2023)

Serotonin and CGRP in Migraine
por: Aggarwal, Milan, et al.
Publicado: (2012)

Care Gaps and Recommendations in Vestibular Migraine: An Expert Panel Summit
por: Mallampalli, Monica P., et al.
Publicado: (2022)

Endolymphatic Hydrops in Patients With Vestibular Migraine and Concurrent Meniere's Disease
por: Oh, Sun-Young, et al.
Publicado: (2021)

Case report: Monoclonal CGRP-antibody treatment in a migraine patient with a mutation in the mitochondrial single-strand binding protein (SSBP1)
por: Kaltseis, Katharina, et al.
Publicado: (2022)

Plasma Levels of CGRP During a 2-h Infusion of VIP in Healthy Volunteers and Patients With Migraine: An Exploratory Study
por: Pellesi, Lanfranco, et al.
Publicado: (2022)

Postural Instability Induced by Visual Motion Stimuli in Patients With Vestibular Migraine
por: Lim, Yong-Hyun, et al.
Publicado: (2018)

Head shaking does not alter vestibulo ocular reflex gain in vestibular migraine
por: Patel, Priyani, et al.
Publicado: (2022)

Sensory organization of balance control in children with vestibular migraine and recurrent vertigo of childhood
por: Li, Xiaofei, et al.
Publicado: (2022)

Gender aspects of CGRP in migraine
por: Labastida-Ramírez, Alejandro, et al.
Publicado: (2017)

CGRP and the Trigeminal System in Migraine
por: Iyengar, Smriti, et al.
Publicado: (2019)

Severity and Its Contributing Factors in Patients With Vestibular Migraine: A Cohort Study
por: Liu, Wei, et al.
Publicado: (2020)

Future targets for migraine treatment beyond CGRP
por: Al-Hassany, Linda, et al.
Publicado: (2023)

Effectiveness of Transcranial Direct Current Stimulation and Monoclonal Antibodies Acting on the CGRP as a Combined Treatment for Migraine (TACTIC): Protocol for a Randomized, Double-Blind, Sham-Controlled Trial
por: Ornello, Raffaele, et al.
Publicado: (2022)

The plasma fibrinogen levels in the nitroglycerin-induced chronic migraine rat model and its association between migraine-associated vestibular dysfunction
por: Zhang, Jilei, et al.
Publicado: (2023)

CGRP as a Migraine Inducing Substance
por: Olesen, J., et al.
Publicado: (2001)

Clinical Features of Headache in Patients With Diagnosis of Definite Vestibular Migraine: The VM-Phenotypes Projects
por: Teggi, Roberto, et al.
Publicado: (2018)

Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
por: Tso, Amy R., et al.
Publicado: (2017)

Benign Recurrent Vertigo: The Course of Vertigo Attacks Compared to Patients With Menière's Disease and Vestibular Migraine
por: van Leeuwen, Roeland B., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u28cpv876d2g0kr8lo0i5dg0dd